Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, addressing dysregulated growth and hyperactive signaling in rare genetic and age-related diseases
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, addressing dysregulated growth and hyperactive signaling in rare genetic and age-related diseases.
The top three firms on F4's Biotech & Life Sciences investor list.